Selected research
Market Structure
Global Menopause Blood Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Menopause Blood Test market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Menopause Blood Test is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Menopause Blood Test include Thriva, MyHealthChecked, Forth, Labcorp OnDemand, Randox, Mina Health, OptimallyMe, Welzo and Quest, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Menopause Blood Test market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Menopause Blood Test and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Menopause Blood Test revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Menopause Blood Test market size, projected growth trends, production technologies, key applications, and end-use industries.
Menopause Blood Test Segment by Company
Thriva
MyHealthChecked
Forth
Labcorp OnDemand
Randox
Mina Health
OptimallyMe
Welzo
Quest
LifeCell
High Trees Clinics
Thorne HealthTech
Everlywell
ZRT Laboratory
Medichecks
Menopause Blood Test Segment by Type
Fingerstick Blood
Venous Blood
Menopause Blood Test Segment by Application
Premenopausal
Postmenopausal
Menopause Blood Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Blood Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Menopause Blood Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Blood Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Menopause Blood Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Menopause Blood Test industry.
Chapter 3: Detailed analysis of Menopause Blood Test companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Menopause Blood Testrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Fingerstick Blood
- Venous Blood
Applications
- Premenopausal
- Postmenopausal
Companies covered
- Thriva
- MyHealthChecked
- Forth
- Labcorp OnDemand
- Randox
- Mina Health
- OptimallyMe
- Welzo
- Quest
- LifeCell
- High Trees Clinics
- Thorne HealthTech
- Everlywell
- ZRT Laboratory
- Medichecks
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Menopause Blood Test Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Fingerstick Blood
- 1.2.3 Venous Blood
- 1.3 Market Analysis by Application
- 1.3.1 Global Menopause Blood Test Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Premenopausal
- 1.3.3 Postmenopausal
- 1.4 Global Market Growth Prospects
- 1.5 Global Menopause Blood Test Growth Trends by Region
- 1.5.1 Global Menopause Blood Test Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Menopause Blood Test Market Size by Region (2021-2026)
- 1.5.3 Menopause Blood Test Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Menopause Blood Test Market Dynamics
- 2.1 Menopause Blood Test Industry Trends
- 2.2 Menopause Blood Test Industry Drivers
- 2.3 Menopause Blood Test Industry Opportunities and Challenges
- 2.4 Menopause Blood Test Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Menopause Blood Test Revenue by Company (2021-2026)
- 3.2 Global Menopause Blood Test Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Menopause Blood Test Key Company Head office and Area Served
- 3.4 Global Menopause Blood Test Company, Product Type & Application
- 3.5 Global Menopause Blood Test Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Menopause Blood Test Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Menopause Blood Test Players Market Share by Revenue in 2025
- 3.6.3 2025 Menopause Blood Test Tier 1, Tier 2, and Tier 3
4 Menopause Blood Test Market by Type
- 4.1 Global Menopause Blood Test Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Menopause Blood Test Market Size by Type (2021-2032)
- 4.3 Global Menopause Blood Test Market Size Share by Type (2021-2032)
5 Menopause Blood Test Market by Application
- 5.1 Global Menopause Blood Test Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Menopause Blood Test Market Size by Application (2021-2032)
- 5.3 Global Menopause Blood Test Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Thriva
- 6.1.1 Thriva Company Information
- 6.1.2 Thriva Business Overview
- 6.1.3 Thriva Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Thriva Menopause Blood Test Product Portfolio
- 6.1.5 Thriva Recent Developments
- 6.2 MyHealthChecked
- 6.2.1 MyHealthChecked Company Information
- 6.2.2 MyHealthChecked Business Overview
- 6.2.3 MyHealthChecked Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 MyHealthChecked Menopause Blood Test Product Portfolio
- 6.2.5 MyHealthChecked Recent Developments
- 6.3 Forth
- 6.3.1 Forth Company Information
- 6.3.2 Forth Business Overview
- 6.3.3 Forth Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Forth Menopause Blood Test Product Portfolio
- 6.3.5 Forth Recent Developments
- 6.4 Labcorp OnDemand
- 6.4.1 Labcorp OnDemand Company Information
- 6.4.2 Labcorp OnDemand Business Overview
- 6.4.3 Labcorp OnDemand Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Labcorp OnDemand Menopause Blood Test Product Portfolio
- 6.4.5 Labcorp OnDemand Recent Developments
- 6.5 Randox
- 6.5.1 Randox Company Information
- 6.5.2 Randox Business Overview
- 6.5.3 Randox Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Randox Menopause Blood Test Product Portfolio
- 6.5.5 Randox Recent Developments
- 6.6 Mina Health
- 6.6.1 Mina Health Company Information
- 6.6.2 Mina Health Business Overview
- 6.6.3 Mina Health Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Mina Health Menopause Blood Test Product Portfolio
- 6.6.5 Mina Health Recent Developments
- 6.7 OptimallyMe
- 6.7.1 OptimallyMe Company Information
- 6.7.2 OptimallyMe Business Overview
- 6.7.3 OptimallyMe Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 OptimallyMe Menopause Blood Test Product Portfolio
- 6.7.5 OptimallyMe Recent Developments
- 6.8 Welzo
- 6.8.1 Welzo Company Information
- 6.8.2 Welzo Business Overview
- 6.8.3 Welzo Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Welzo Menopause Blood Test Product Portfolio
- 6.8.5 Welzo Recent Developments
- 6.9 Quest
- 6.9.1 Quest Company Information
- 6.9.2 Quest Business Overview
- 6.9.3 Quest Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Quest Menopause Blood Test Product Portfolio
- 6.9.5 Quest Recent Developments
- 6.10 LifeCell
- 6.10.1 LifeCell Company Information
- 6.10.2 LifeCell Business Overview
- 6.10.3 LifeCell Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 LifeCell Menopause Blood Test Product Portfolio
- 6.10.5 LifeCell Recent Developments
- 6.11 High Trees Clinics
- 6.11.1 High Trees Clinics Company Information
- 6.11.2 High Trees Clinics Business Overview
- 6.11.3 High Trees Clinics Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 High Trees Clinics Menopause Blood Test Product Portfolio
- 6.11.5 High Trees Clinics Recent Developments
- 6.12 Thorne HealthTech
- 6.12.1 Thorne HealthTech Company Information
- 6.12.2 Thorne HealthTech Business Overview
- 6.12.3 Thorne HealthTech Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Thorne HealthTech Menopause Blood Test Product Portfolio
- 6.12.5 Thorne HealthTech Recent Developments
- 6.13 Everlywell
- 6.13.1 Everlywell Company Information
- 6.13.2 Everlywell Business Overview
- 6.13.3 Everlywell Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Everlywell Menopause Blood Test Product Portfolio
- 6.13.5 Everlywell Recent Developments
- 6.14 ZRT Laboratory
- 6.14.1 ZRT Laboratory Company Information
- 6.14.2 ZRT Laboratory Business Overview
- 6.14.3 ZRT Laboratory Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 ZRT Laboratory Menopause Blood Test Product Portfolio
- 6.14.5 ZRT Laboratory Recent Developments
- 6.15 Medichecks
- 6.15.1 Medichecks Company Information
- 6.15.2 Medichecks Business Overview
- 6.15.3 Medichecks Menopause Blood Test Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Medichecks Menopause Blood Test Product Portfolio
- 6.15.5 Medichecks Recent Developments
7 North America
- 7.1 North America Menopause Blood Test Market Size (2021-2032)
- 7.2 North America Menopause Blood Test Market Size by Type
- 7.2.1 North America Menopause Blood Test Market Size by Type (2021-2026)
- 7.2.2 North America Menopause Blood Test Market Size by Type (2027-2032)
- 7.2.3 North America Menopause Blood Test Market Share by Type (2021-2032)
- 7.3 North America Menopause Blood Test Market Size by Application
- 7.3.1 North America Menopause Blood Test Market Size by Application (2021-2026)
- 7.3.2 North America Menopause Blood Test Market Size by Application (2027-2032)
- 7.3.3 North America Menopause Blood Test Market Share by Application (2021-2032)
- 7.4 North America Menopause Blood Test Market Size by Country
- 7.4.1 North America Menopause Blood Test Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Menopause Blood Test Market Size by Country (2021-2026)
- 7.4.3 North America Menopause Blood Test Market Size by Country (2027-2032)
- 7.4.4 North America Menopause Blood Test Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Menopause Blood Test Market Size (2021-2032)
- 8.2 Europe Menopause Blood Test Market Size by Type
- 8.2.1 Europe Menopause Blood Test Market Size by Type (2021-2026)
- 8.2.2 Europe Menopause Blood Test Market Size by Type (2027-2032)
- 8.2.3 Europe Menopause Blood Test Market Share by Type (2021-2032)
- 8.3 Europe Menopause Blood Test Market Size by Application
- 8.3.1 Europe Menopause Blood Test Market Size by Application (2021-2026)
- 8.3.2 Europe Menopause Blood Test Market Size by Application (2027-2032)
- 8.3.3 Europe Menopause Blood Test Market Share by Application (2021-2032)
- 8.4 Europe Menopause Blood Test Market Size by Country
- 8.4.1 Europe Menopause Blood Test Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Menopause Blood Test Market Size by Country (2021-2026)
- 8.4.3 Europe Menopause Blood Test Market Size by Country (2027-2032)
- 8.4.4 Europe Menopause Blood Test Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Menopause Blood Test Market Size (2021-2032)
- 9.2 China Menopause Blood Test Market Size by Type
- 9.2.1 China Menopause Blood Test Market Size by Type (2021-2026)
- 9.2.2 China Menopause Blood Test Market Size by Type (2027-2032)
- 9.2.3 China Menopause Blood Test Market Share by Type (2021-2032)
- 9.3 China Menopause Blood Test Market Size by Application
- 9.3.1 China Menopause Blood Test Market Size by Application (2021-2026)
- 9.3.2 China Menopause Blood Test Market Size by Application (2027-2032)
- 9.3.3 China Menopause Blood Test Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Menopause Blood Test Market Size (2021-2032)
- 10.2 Asia Menopause Blood Test Market Size by Type
- 10.2.1 Asia Menopause Blood Test Market Size by Type (2021-2026)
- 10.2.2 Asia Menopause Blood Test Market Size by Type (2027-2032)
- 10.2.3 Asia Menopause Blood Test Market Share by Type (2021-2032)
- 10.3 Asia Menopause Blood Test Market Size by Application
- 10.3.1 Asia Menopause Blood Test Market Size by Application (2021-2026)
- 10.3.2 Asia Menopause Blood Test Market Size by Application (2027-2032)
- 10.3.3 Asia Menopause Blood Test Market Share by Application (2021-2032)
- 10.4 Asia Menopause Blood Test Market Size by Country
- 10.4.1 Asia Menopause Blood Test Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Menopause Blood Test Market Size by Country (2021-2026)
- 10.4.3 Asia Menopause Blood Test Market Size by Country (2027-2032)
- 10.4.4 Asia Menopause Blood Test Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Menopause Blood Test Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Menopause Blood Test Market Size by Type
- 11.2.1 South America, Middle East & Africa Menopause Blood Test Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Menopause Blood Test Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Menopause Blood Test Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Menopause Blood Test Market Size by Application
- 11.3.1 South America, Middle East & Africa Menopause Blood Test Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Menopause Blood Test Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Menopause Blood Test Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Menopause Blood Test Market Size by Country
- 11.4.1 South America, Middle East & Africa Menopause Blood Test Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Menopause Blood Test Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Menopause Blood Test Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Menopause Blood Test Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst